Moreover, interestingly, as depicted in Figure 4C, starting on day 14 and afterwards on day 17 and day 20 post-tumor injection, a significant decrease in tumor growth rate in C51 FL Rnaset2-injected mice was observed when compared to C51 P-injected control mice. The gene discussed is RNASET2; the disease is neoplasm.